Home >> Marketplace Directory >> NGS service for bacterial infection monitoring

, 1/16

NGS service for bacterial infection monitoring

, 1/16

image_pdfCreate PDF

 

January 2016—BioMérieux and Illumina announced the launch of BioMérieux EpiSeq, a next-generation sequencing service dedicated to the epidemiological monitoring and control of health care–associated infections. The EpiSeq service is the first result of the collaboration agreement signed by the two companies in November 2014.

Hospitals facing a suspected epidemic or health crisis will be able to send bacterial isolates to a service laboratory designated by BioMérieux and equipped with an Illumina MiSeq sequencer. The genomic data are stored in a secure cloud platform and analyzed using the database and software developed by BioMérieux. Results showing the genomic profile of the infectious agents and the genetic variations identified by sequencing will be sent by BioMérieux to health care professionals in a customized, easy-to-interpret report.

The EpiSeq service will first be launched in Europe followed by North America and Asia. The menu will initially consist of Staphylococcus aureus and will subsequently be expanded to include the other bacterial species most commonly responsible for health care–associated infections.

BioMérieux, + 33 4 78 87 54 75

CAP TODAY
X